About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Kidney Disease Clinical Trials in Chicago | 134 Studies

Clinical Trials Kidney DiseaseChicago

Kidney Disease Clinical Trials in Chicago

Find 134 clinical trials for kidney disease near Chicago, Illinois. Connect with research centers in your area.

All Kidney Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 134 trials

CompletedAnemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)This will be an open-label, randomized, parallel-group study in hemodialysis-dependent (HD) participants with anemia associated with chronic kidney disease (CKD), designed to…NCT03029247·La Mesa, California and 10 others CompletedA 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on DialysisThis is up to a 58 week study comparing ferric citrate to active control for 52 weeks in ESRD dialysis patients, and subsequently comparing ferric citrate to placebo for 4 weeks.NCT01191255·Tempe, Arizona and 55 others

Kidney Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedEvaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorProspective, Randomized, Double-Blind, Placebo-Controlled Multicenter Study.NCT01356849·Pell City, Alabama and 71 others

Active not recruitingSPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTNThe purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in subjects treated with renal…NCT05198674·Birmingham, Alabama and 96 others

RecruitingProteogenomic Monitoring and Assessment of Liver Transplant RecipientsThis study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus)…NCT01644903·Chicago, Illinois

RecruitingA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compared with placebo in participants…NCT07753993·Huntsville, Alabama and 714 others

TerminatedEvaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on HemodialysisTo evaluate the survival benefit associated with Zemplar therapy as compared to Calcijex for the treatment of secondary hyperparathyroidism in subjects with Stage V chronic kidney…NCT00062699·Tuscaloosa, Alabama and 59 others

TerminatedPrevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring HemodialysisThe purpose of this study is to determine the effect of recipient vein pretreatment of edifoligide (E2F Decoy), compared to placebo, on graft/recipient vein stenosis in…NCT00086164·Los Angeles, California and 20 others

RecruitingBreakthrough - T1DM and Chronic Kidney DiseaseSingle arm- subject treated with Tegoprubart and everolimus.NCT07592000·Miami, Florida and 1 other

CompletedPhase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseThis study assesses the effects of a new formulation of bardoxolone methyl on eGFR in Patients with Chronic Kidney Disease and Type 2 Diabetes.NCT01053936·Montgomery, Alabama and 25 others

CompletedA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseThis study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse.NCT06926660·Huntsville, Alabama and 156 others

CompletedAfrican American Study of Kidney Disease and Hypertension ABPM Pilot Study4\. Methods 4a.NCT00582777·Birmingham, Alabama and 15 others

RecruitingKidney Precision Medicine ProjectAcute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden.NCT04334707·Tucson, Arizona and 12 others

CompletedTacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE ScoreThe TEAMMATE Trial will enroll 210 pediatric heart transplant patients from 25 centers at 6 months post-transplant and follow each patient for 2.5 years.NCT03386539·Birmingham, Alabama and 24 others

CompletedEfficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in participants with Non-dialysis-dependent Chronic Kidney Disease…NCT02680574·Birmingham, Alabama and 502 others

CompletedContinuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis PatientsThe purpose of this study is to confirm the safety and efficacy of Soluble Ferric Pyrophosphate (SFP) dialysate solution in maintaining iron delivery for erythropoiesis in anemic…NCT01320202·Bakersfield, California and 46 others

CompletedPROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD PatientsThe purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in…NCT00440466·Chula Vista, California and 65 others

CompletedA Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesThe main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or…NCT05936151·Chandler, Arizona and 41 others

Active not recruitingProact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseThe purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.NCT05099770·Huntsville, Alabama and 87 others

TerminatedThe PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5To evaluate the effects of paricalcitol injection on cardiac structure and function over 48 weeks in subjects with Stage 5 Chronic Kidney Disease (CKD) receiving hemodialysis who…NCT00616902·Phoenix, Arizona and 75 others

PreviousPage 5 of 7Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia